UniPharma Co., Ltd. (6621.TWO)

TWD 15.4

(-2.6%)

Operating Expenses Summary of UniPharma Co., Ltd.

  • UniPharma Co., Ltd.'s latest annual operating expenses in 2023 was 78.32 Million TWD , down -17.98% from previous year.
  • UniPharma Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 19.26 Million TWD , up 9.57% from previous quarter.
  • UniPharma Co., Ltd. reported a annual operating expenses of 95.49 Million TWD in annual operating expenses 2022, down -4.07% from previous year.
  • UniPharma Co., Ltd. reported a annual operating expenses of 99.54 Million TWD in annual operating expenses 2021, up 10.69% from previous year.
  • UniPharma Co., Ltd. reported a quarterly operating expenses of 19.26 Million TWD for 2024 Q2, up 9.57% from previous quarter.
  • UniPharma Co., Ltd. reported a quarterly operating expenses of 20.02 Million TWD for 2023 Q3, up 15.26% from previous quarter.

Annual Operating Expenses Chart of UniPharma Co., Ltd. (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Expenses20192019.520202020.520212021.520222022.5202375000000 TWD80000000 TWD85000000 TWD90000000 TWD95000000 TWD100000000 TWD105000000 TWD

Historical Annual Operating Expenses of UniPharma Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 78.32 Million TWD -17.98%
2022 95.49 Million TWD -4.07%
2021 99.54 Million TWD 10.69%
2020 89.93 Million TWD -10.42%
2019 100.38 Million TWD 0.0%

Peer Operating Expenses Comparison of UniPharma Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Allied Biotech Corporation 157.72 Million TWD 50.343%
GeneFerm Biotechnology Co., Ltd. 132.78 Million TWD 41.017%
Easywell Biomedicals, Inc. 333.45 Million TWD 76.512%
TTY Biopharm Company Limited 1.91 Billion TWD 95.903%
Synmosa Biopharma Corporation 1.49 Billion TWD 94.777%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 96.352%
Center Laboratories, Inc. 697.35 Million TWD 88.769%
Tien Liang BioTech Co., Ltd. 267.27 Million TWD 70.696%
Orient Pharma Co., Ltd. 468.66 Million TWD 83.289%
InnoPharmax Inc. 82.29 Million TWD 4.83%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD 67.984%
Excelsior Biopharma Inc. 388.05 Million TWD 79.817%
DV Biomed Co., Ltd. 575.24 Million TWD 86.385%
Foresee Pharmaceuticals Co., Ltd. 1.12 Billion TWD 93.017%
Handa Pharmaceuticals, Inc. 399.14 Million TWD 80.378%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 80.269%
Alar Pharmaceuticals Inc. 83.74 Million TWD 6.477%
Winston Medical Supply Co., Ltd. 151.49 Million TWD 48.302%
Mercury Biopharmaceutical Corporation 592 Thousand TWD -13129.899%
Bioray Biotech Co., Ltd 96.98 Million TWD 19.242%
TSH Biopharm Corporation Limited 336.26 Million TWD 76.709%